Niclocide
(Niclosamide)ApprovedSmall molecule
BayerNiclosamide is used to treat infections caused by tapeworms and other parasitic worms that live in the intestines. It works by killing the worms so they can be eliminated from the body.[2] Niclocide is currently approved and in use across 12 indications[4].[1]
Niclocide is one of 298 small molecule programs targeting Familial adenomatous polyposis. It is currently in Approved.
12
Indications
23
Total Trials
2
Active Trials
297
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 12 indications
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Niclocide
BayerApproved
Biaxin
AbbViePreclinical
Singulair
AstraZenecaPreclinical
Angiomax
BBaxter Healthcare Corporation
Preclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Low-Molecular-Weight Heparin
Daiichi SankyoPreclinical
SARS-COV-2 VACCINE
ModernaPreclinical
Orap
TevaPreclinical
Biological Data
UUniversity Hospital, Bordeaux
Preclinical
Blood Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
COVID-199 trials
Show 6 more trials
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
Completed·—·Phase 2/3·NCT04870333·2,240 enrolled
Prostate Cancer2 trials
Proctosigmoiditis1 trial
9 more indications
Treatment1 trial
Mass Treatment T Solium Community Study
Terminated·NNational Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00138359·4,200 enrolled
Colorectal Cancer1 trial
Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy
Unknown status·—·Phase 2·NCT02519582·37 enrolled
Regulatory
FDA Approval Timeline[5]
May 14, 1982
NICLOCIDE
NDA NDA018669
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Niclocide drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Niclosamide. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]